Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1976;54:761-765

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Awan, N. A.
Right arrow Articles by Mason, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Awan, N. A.
Right arrow Articles by Mason, D. T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Hazardous Substances DB
*NITROGLYCERIN

Circulation, Vol 54, 761-765, Copyright © 1976 by American Heart Association


ARTICLES

Reduction of ischemic injury by sublingual nitroglycerin in patients with acute myocardial infarction

NA Awan, EA Amsterdam, Z Vera, AN DeMaria, RR Miller and DT Mason

The effect of sublingual nitroglycerin (NTG) on myocardial ischemic injury was evaluated in eleven patients with acute anterior myocardial infarction. Precordial 35-lead ST-segment maps were obtained in each patient immediately before and 3-10 minutes after 0.4 mg sublingual NTG. The following measurements were made from each ST map: N-ST (number of leads showing ST elevation greater than 1mm), sigmaST (total ST elevation in all leads), ST (average ST-segment elevation in those leads with less than 1mm elevation). Following 0.4 mg sublingual NTG evidence of myocardial ischemic injury as assessed by ST-segment mapping decreased in association with reduction of heart rate X systolic blood pressure product (10.80 X 10(3) to 9.49 X 10(3), P less than 0.001). Group mean values diminished significantly for N-ST (18.1 to 14.4, P less than 0.001), sigma ST (37.9 to 30.1 P less than 0.005) and ST (1.7 to 1.4, P less than 0.001). Evaluation performed by the technique of precordial ST-segment mapping suggests that sublingual nitroglycerin in a commonly employed clinical dose is associated with evidence of reduced ischemic cardiac injury in patients with acute myocardial infarction. This effect appears to be related to reduction of myocardial oxygen demand by the nitrate.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
R. E. RUDE, J. E. MULLER, and B. EUGENE
Efforts to Limit the Size of Myocardial Infarcts
Ann Intern Med, December 1, 1981; 95(6): 736 - 761.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
Z. Vera
Peripheral Circulation in Cardiovascular Disease
Arch Intern Med, December 1, 1977; 137(12): 1673 - 1674.
[Abstract] [PDF]